"Upstate Community Hospital is a nationally recognized health care facility that offers a comprehensive range of services, including medical and surgical care, emergency services, intensive care, acute rehabilitation and inpatient psychiatric care. The 306-bed hospital has been named a "Thomson Reuters 100 Top Hospitals: Performance Improvement Leader," and is also nationally recognized for its premier orthopedic program, spine surgery, bariatric surgery and maternity services. The hospital is rated number one in New York State for orthopedic services by HealthGrades (2007-2010). The hospital is also the only hospital in Central New York with a five-star rating for prostate surgery (2007-2010)."

During the past decade, SUNY Upstate Medical Center-Community Campus conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SUNY Upstate Medical Center-Community Campus" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "NRG Oncology" with 3 trials sponsored and "Canadian Cancer Trials Group" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SUNY Upstate Medical Center-Community Campus" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "SUNY Upstate Medical Center-Community Campus" are "Stage IIIA Breast Cancer" (6 trials), "Stage II Breast Cancer" (5 trials), "Stage IIA Breast Cancer" (4 trials), "Stage IIB Breast Cancer" (4 trials) and "Invasive Breast Carcinoma" (3 trials). Many other conditions were trialed in "SUNY Upstate Medical Center-Community Campus" in a lesser frequency.

Most popular intervention types in "SUNY Upstate Medical Center-Community Campus" are "Drug" (21 trials), "Other" (14 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Carboplatin" (6 trials), "Cisplatin" (5 trials), "Computed Tomography" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "SUNY Upstate Medical Center-Community Campus" are 21 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "SUNY Upstate Medical Center-Community Campus". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SUNY Upstate Medical Center-Community Campus, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SUNY Upstate Medical Center-Community Campus, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".